Joanna Poutou Ottawa Hospital Research Institute Biography Publications Institution JoVE Articles Joanna Poutou has not added a biography. If you are Joanna Poutou and would like to personalize this page please email our Author Liaison for assistance. Publications A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion Nanomaterials (Basel, Switzerland). Mar, 2021 | Pubmed ID: 33809836 Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction International Journal of Molecular Sciences. Feb, 2021 | Pubmed ID: 33668756 Nanoluciferase Complementation-based Bioreporter Reveals the Importance of N-linked Glycosylation of SARS-CoV-2 S for Viral Entry Molecular Therapy : the Journal of the American Society of Gene Therapy. Jun, 2021 | Pubmed ID: 33578036 Redirecting Oncolytic Viruses: Engineering Opportunists to Take Control of the Tumour Microenvironment Cytokine & Growth Factor Reviews. 12, 2020 | Pubmed ID: 32958389 Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization Membranes. Aug, 2020 | Pubmed ID: 32872641 Enhanced Therapeutic Effect Using Sequential Administration of Antigenically Distinct Oncolytic Viruses Expressing Oncostatin M in a Syrian Hamster Orthotopic Pancreatic Cancer Model Molecular Cancer. Dec, 2015 | Pubmed ID: 26671477 Nachweis eines SARS-CoV-2-Rezeptor-bindenden Domänenantikörpers mit einem HiBiT-basierten Bioreporter Reza Rezaei1,2, Abera Surendran1,2, Ragunath Singaravelu1,2, Taylor R. Jamieson1,2, Parisa Taklifi3, Joanna Poutou1,2, Taha Azad1,2, Carolina S. Ilkow1,2 1Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 3Department of Biotechnology, University of Tehran JoVE 62488 Immunologie et Infection Nachweis von SARS-CoV-2 neutralisierenden Antikörpern mittels Hochdurchsatz-Fluoreszenzbildgebung von Pseudovirus-Infektionen Taylor R. Jamieson1,2, Joanna Poutou1,2, Ricardo Marius1,2, Xiaohong He1, Reza Rezaei1,2, Taha Azad1,2, Carolina S. Ilkow1,2 1Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology, University of Ottawa JoVE 62486 Immunologie et Infection
Nachweis eines SARS-CoV-2-Rezeptor-bindenden Domänenantikörpers mit einem HiBiT-basierten Bioreporter Reza Rezaei1,2, Abera Surendran1,2, Ragunath Singaravelu1,2, Taylor R. Jamieson1,2, Parisa Taklifi3, Joanna Poutou1,2, Taha Azad1,2, Carolina S. Ilkow1,2 1Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 3Department of Biotechnology, University of Tehran JoVE 62488 Immunologie et Infection
Nachweis von SARS-CoV-2 neutralisierenden Antikörpern mittels Hochdurchsatz-Fluoreszenzbildgebung von Pseudovirus-Infektionen Taylor R. Jamieson1,2, Joanna Poutou1,2, Ricardo Marius1,2, Xiaohong He1, Reza Rezaei1,2, Taha Azad1,2, Carolina S. Ilkow1,2 1Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology, University of Ottawa JoVE 62486 Immunologie et Infection